Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin.
Kenneth Bentum OtabilSamuel Fosu GyasiEsi AwuahDaniels Obeng-OforiRobert Junior Atta-NyarkoDominic AndohBeatrice ConduahLawrence AgbenyikeyPhilip AseiduComfort Blessing AnkrahAbdul Razak NuhuH D F H SchalligPublished in: BMC infectious diseases (2019)
The study showed that despite several years of mass drug administration with ivermectin, infection with onchocerciasis and the commonly associated clinical manifestations of the disease still persist in the study communities. This calls for a greater urgency for research and development aimed at discovering new or repurposed anti-filarial agents which will augment ivermectin if global onchocerciasis eradication targets are to be achieved.